ReviewAnnals of oncology : official journal of the European Society for Medical Oncology2017

Do patient access schemes for high-cost cancer drugs deliver value to society?-lessons from the NHS Cancer Drugs Fund.

A Aggarwal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.